this report compares the effects of human menopausal gonadotropin ( hmg ) and purified urinary human follicle-stimulating hormone ( hfsh ) protocols in patients with irreparable tubal disease as the sole indication for in vitro fertilization-embryo transfer ( ivf-et ) .
C0025326
human menopausal gonadotropin
C0524639
urinary human follicle-stimulating hormone